The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete.
The reader should not assume that the information is accurate and complete.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 13F

FORM 13F INFORMATION TABLE
OMB APPROVAL
OMB Number: 3235-0006
Estimated average burden
hours per response: 23.8
COLUMN 1 COLUMN 2 COLUMN 3 COLUMN 4 COLUMN 5 COLUMN 6 COLUMN 7 COLUMN 8
VALUE SHRS OR SH/ PUT/ INVESTMENT OTHER VOTING AUTHORITY
NAME OF ISSUER TITLE OF CLASS CUSIP (x$1000) PRN AMT PRN CALL DISCRETION MANAGER SOLE SHARED NONE
ICOSAVAX INC COM 45114M109 4,303 1,361,658 SH   SOLE   1,361,658 0 0
SELECTA BIOSCIENCES INC COM 816212104 6,212 3,787,515 SH   SOLE   3,787,515 0 0
SQZ BIOTECHNOLOGIES CO COM 78472W104 3,295 1,445,221 SH   SOLE   1,445,221 0 0
TWIST BIOSCIENCE CORP COM 90184D100 10,845 307,740 SH   SOLE   307,740 0 0